Blood test picks out cancers likely to benefit from targeted drugs
Read more here
Shorter radiotherapy course reduces risk of bladder cancer returning
Read moreHighlights
Research is key to future treatment
Our six research themes and two cross-cutting themes bring together a critical mass of internationally renowned clinicians, scientists and allied health professionals, allowing us to ensure that novel diagnostics and physical and systemic therapies are rapidly available to all cancer patients.
Patient and public involvement and engagement
Involving patients and the public with our research ensures that we focus on the issues that matter most to those affected by cancer.
Find out moreLatest news
First Covid jab provides protection
A single dose of a Covid-19 vaccine triggers an immune response in around 70 per cent of myeloma blood cancer patients – suggesting that it does provide protection against the virus.
Find out more
Resistance-busting drug enters clinical trial
A drug discovered at the Institute of Cancer Research that could counteract drug resistance in various cancers has entered a phase I clinical trial at The Royal Marsden NHS Foundation Trust.
Find out more
Early promise in treating aggressive brain cancers
Early results from a Phase I trial suggest immunotherapy combined with an experimental cancer drug could offer a new way of treating some patients with aggressive brain cancers.
Find out more